Completed NA INTERVENTIONAL 1-arm NCT02276573

Study of Inflammatory Role of Epstein-Barr Virus (EBV) in Atrophic and Erosive Forms of Oral Lichen Planus (LICHENVIR)

Sponsor: Centre Hospitalier Universitaire de Nice

Updated 7 times since 2017 Last updated: Nov 15, 2023 Started: Mar 30, 2015 Primary completion: Mar 10, 2016 Completion: Mar 10, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02276573, this NA trial focuses on Lichen Planus, Oral and remains completed. Sponsored by Centre Hospitalier Universitaire de Nice, it has been updated 7 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Dec 2023 — Jul 2024 [monthly]

Completed NA

Status: Unknown Status → Completed
Jan 2021 — Dec 2023 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA

▶ Show 2 earlier versions

Aug 2017 — Jun 2018 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jan 2017 — Aug 2017 [monthly]

Recruiting NA

First recorded

Mar 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre Hospitalier Universitaire de Nice

Data source: Centre Hospitalier Universitaire de Nice

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nice, France